Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies, today announced that Richard Murray, Ph.D., chief executive officer, will present a company overview at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13 at 10 a.m. PT at the Westin St. Francis Hotel in San Francisco. The overview will include an update on the Jounce’s translational science platform, immune-oncology patient selection strategy and cancer immunotherapy portfolio overview.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
